Big Data in Pharmaceutical R&D: Creating a Sustainable R&D Engine

Por Tormay, Peter
Publicado no Pharmaceut Med (2015)

Comparative cell signalling activity of ultrapure recombinant chaperonin 60 proteins from prokaryotes and eukaryotes

Por Maguire, Maria, Poole, Stephen, Coates, Anthony R M, Tormay, Peter, Wheeler-Jones, Caroline, Henderson, Brian
Publicado em 2005

Rhizobium leguminosarum chaperonin 60.3, but not chaperonin 60.1, induces cytokine production by human monocytes: activity is dependent on interaction with cell surface CD14

Por Lewthwaite, Jo, George, Roger, Lund, Peter A., Poole, Steve, Tormay, Peter, Sharp, Lindsay, Coates, Anthony R.M., Henderson, Brian
Publicado em 2002

Comparison of the Moonlighting Actions of the Two Highly Homologous Chaperonin 60 Proteins of Mycobacterium tuberculosis

Por Cehovin, Ana, Coates, Anthony R. M., Hu, Yanmin, Riffo-Vasquez, Yanira, Tormay, Peter, Botanch, Catherine, Altare, Frederic, Henderson, Brian
Publicado em 2010

A Mycobacterium tuberculosis Mutant Lacking the groEL Homologue cpn60.1 Is Viable but Fails To Induce an Inflammatory Response in Animal Models of Infection

Por Hu, Yanmin, Henderson, Brian, Lund, Peter A., Tormay, Peter, Ahmed, M. Tabish, Gurcha, Sudagar S., Besra, Gurdyal S., Coates, Anthony R. M.
Publicado em 2008

Mycobacterium tuberculosisChaperonin 60.1 Is a More Potent Cytokine Stimulator than Chaperonin 60.2 (Hsp 65) and Contains a CD14-Binding Domain

Por Lewthwaite, Jo C., Coates, Anthony R. M., Tormay, Peter, Singh, Mahavir, Mascagni, Paolo, Poole, Stephen, Roberts, Michael, Sharp, Lindsay, Henderson, Brian
Publicado em 2001